本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rapport Therapeutics, Inc.

41.39
-1.2900-3.02%
盤後41.390.00000.00%19:30 EDT
成交量:38.70萬
成交額:1,618.60萬
市值:19.86億
市盈率:-13.56
高:43.67
開:42.82
低:41.23
收:42.68
52周最高:52.93
52周最低:23.75
股本:4,797.83萬
流通股本:3,039.38萬
量比:1.39
換手率:1.27%
股息:- -
股息率:- -
每股收益(TTM):-3.0525
每股收益(LYR):-2.8633
淨資產收益率:-39.96%
總資產收益率:-25.78%
市淨率:4.70
市盈率(LYR):-14.46

資料載入中...

2026/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

重要事件披露

Form 8-K - Current report
2026/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/21

重要事件披露

Form 8-K - Current report
2026/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities